A new issue of QuarterWatch critiques the recent Ciprani meta-analysis on antidepressants and reports on the adverse effects of the newest antidepressant, vortioxetine.
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.
1 COMMENT
-
The antidepressants are out of patent now, but it’s popping up again and again that overall, they are not of great value.